Techniclone Issued Patent Extending Vascular Targeting Agent Portfolio

was issued U.S. Patent No. 6,036,955 on March 14, 2000 entitled “Kits and Methods for the Specific Coagulation of Vasculature” by the U.S. Patent and Trademark Office.

This patent covers particular methods of inducing molecules on tumour blood vessels for subsequent targeting and destruction and is a valuable addition to Techniclone’s existing broad patent portfolio on its Vascular Targeting Agent (VTA) technology.

Dr. John Bonfiglio, Interim President, stated, “We are very happy to have received another patent for Techiclone’s proprietary VTA technology platform. This patent continues to strengthen our already strong patent position in this field.

Clearly the value of Techniclone’s patent position is evidencing itself through negotiations in progress and recently signed letters of intent with Oxigene, Inc. and SuperGen, Inc.”

The VTA technology is Techniclone’s proprietary therapeutic platform designed to specifically target tumour vasculature and subsequently destroy the tumour with various attached therapeutic agents.

Although VEGF alone is being examined by many companies as a target for anti-angiogenisis agents, Techniclone holds the patents for attaching most therapeutic agents to VEGF for the purpose of targeting them to the tumour vasculature.

Dr. Philip Thorpe, Professor of Pharmacology at the University of Texas, Southwestern Medical Centre at Dallas, and the lead inventor of the VTA technology has shown proof of principle with this technology in several animal models, the results of which studies have been published in peer reviewed scientific journals, including Science in 1997.

TECHNICLONE Corporation is a biopharmaceutical company focused on the development, commercialisation and licensing of unique technologies for the treatment of cancer, primarily based on its collateral targeting technologies.

These technologies therapeutically target cell structures and cell types, rather than surface cancer cells, as a means to attack solid tumours, without causing damage to surrounding healthy tissue.

The Company has three collateral technologies: Cotara (T, Vasopermeation Enhancement Agents (VEA), and Vascular Targeting Agents (VTA). The Company also has a direct tumour targeting agent called Oncolym for the treatment of advanced non-Hodgkin’s B-cell Lymphoma.

Oncolym has been licensed to Schering AG, Germany, which is now responsible for all existing and future Oncolym clinical trial programs as well as marketing.

Online Steroids

dragon-pharmaceutical
Dragon Pharma has provided our clients the highest level of pharmacy services throughout the continuum of the overall healthcare system: Deca 300.

Buy Dragon Pharmaceuticals

Primobolan 200

Injectable Anabolic Steroid
Basic Ingredient: Methenolone Enanthate
Branded by: Dragon Pharma LLC
Unit: 1 X 10 mL vial (200 mg/mL)

Sustanon 350 - Bulk Price

Administration: Injection
Active Substance: Testosterone Blend
Produced by: Dragon Pharma
Unit: 10 x 10 mL vial (350 mg/mL)
Price: 10 x $45.00

EQ 200 / Test E 200

Injectable Anabolic Steroid
Basal Constituent: Boldenone Undecylenate, Testosterone Enanthate
Manufacturer: Dragon Pharmaceutical
Amount: 1 X 10 mL vial (400 mg/mL)

Cut Mix 150 - Discount Price

Administration: Injection
Primary Constituent: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Made by: Dragon Pharmaceutical
Unit: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $36.00

EQ 300 - Cheap Price

Administration: Injection
Basal Ingredient: Boldenone Undecylenate
Producer: Dragon Pharmaceutical
Package: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $35.00

Oxymetholon - Bulk Price

Administration: Oral
Prime Ingredient: Oxymetholone
Manufacturer: Dragon Pharma
Pack: 10 x 100 pastilles (50 mg/pill)
Price: 10 x $65.00

Cut Long 300

Injectable Steroid for Muscle Growth
Mix of: Drostanolone Enanthate,
Testosterone Enanthate, Trenbolone Enanthate
Branded by: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (300 mg/mL)

Suspension 100

Injectable Steroid for Muscle Growth
Principal Ingredient: Testosterone Suspension
Manufacturer: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (100 mg/mL)

Winstrol 50

Injectable Steroid for Muscle Growth
Basal Chemical Name: Stanozolol
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (50 mg/mL)

Turanabol

Oral Steroid for Muscle Growth
Basic Component: Chlorodehydromethyltestosterone
Made by: Dragon Pharma
100 tablets (20 mg/pill)

Primobolan 200

Basal Component: Methenolone Enanthate
Branded by: Dragon Pharmaceuticals
Unit: 10 mL vial (200 mg/mL)

Propionat 100

Prime Component: Testosterone Propionate
Manufacturer: Dragon Pharma Labs
Amount: 10 x 10 mL vial (100 mg/mL)